Smith Group Asset Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,000
| Closed | -$306K | – | 182 |
|
2024
Q4 | $306K | Buy |
+2,000
| New | +$306K | 0.02% | 172 |
|
2020
Q2 | – | Sell |
-113,878
| Closed | -$36M | – | 307 |
|
2020
Q1 | $36M | Sell |
113,878
-28,543
| -20% | -$9.03M | 1.97% | 11 |
|
2019
Q4 | $42.3M | Sell |
142,421
-45,972
| -24% | -$13.6M | 1.77% | 11 |
|
2019
Q3 | $43.8M | Sell |
188,393
-43,919
| -19% | -$10.2M | 1.54% | 15 |
|
2019
Q2 | $54.3M | Buy |
232,312
+22,507
| +11% | +$5.26M | 1.82% | 12 |
|
2019
Q1 | $49.6M | Buy |
209,805
+94,314
| +82% | +$22.3M | 1.61% | 16 |
|
2018
Q4 | $34.9M | Buy |
115,491
+27,672
| +32% | +$8.36M | 1.23% | 23 |
|
2018
Q3 | $30.5M | Sell |
87,819
-3,581
| -4% | -$1.24M | 0.87% | 43 |
|
2018
Q2 | $26.8M | Sell |
91,400
-126,807
| -58% | -$37.2M | 0.78% | 52 |
|
2018
Q1 | $59.7M | Sell |
218,207
-4,872
| -2% | -$1.33M | 1.97% | 12 |
|
2017
Q4 | $71.2M | Buy |
223,079
+138,832
| +165% | +$44.3M | 2.24% | 9 |
|
2017
Q3 | $26.4M | Buy |
+84,247
| New | +$26.4M | 0.88% | 39 |
|
2015
Q2 | – | Sell |
-17,770
| Closed | -$7.5M | – | 403 |
|
2015
Q1 | $7.5M | Hold |
17,770
| – | – | 0.25% | 92 |
|
2014
Q4 | $6.03M | Buy |
17,770
+20
| +0.1% | +$6.79K | 0.21% | 98 |
|
2014
Q3 | $5.87M | Buy |
17,750
+100
| +0.6% | +$33.1K | 0.22% | 100 |
|
2014
Q2 | $5.57M | Hold |
17,650
| – | – | 0.21% | 98 |
|
2014
Q1 | $5.4M | Hold |
17,650
| – | – | 0.21% | 97 |
|
2013
Q4 | $4.93M | Hold |
17,650
| – | – | 0.19% | 98 |
|
2013
Q3 | $4.25M | Hold |
17,650
| – | – | 0.18% | 97 |
|
2013
Q2 | $3.8M | Buy |
+17,650
| New | +$3.8M | 0.16% | 113 |
|